Comparing buprenorphine formulations for fentanyl addiction
Treatments studied
Part of Mental health clinical trials.
This study tests two different forms of buprenorphine (a medication for opioid addiction) to see which works better for people who use fentanyl or other strong synthetic opioids. If you are seeking treatment for opioid use, this trial may help you find the most effective option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old and want treatment for opioid addiction.
- You have been using fentanyl or other strong synthetic opioids regularly.
- You have not taken buprenorphine or methadone in the past month.
- You are not pregnant, breastfeeding, or planning pregnancy, and you are willing to use birth control if needed.
- You do not have a serious untreated medical or mental health condition that could make the study unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to quickly start buprenorphine (a medication for opioid addiction) in an outpatient clinic for people who use fentanyl. It aims to make starting treatment easier and faster, without needing to go through full withdrawal first.
This Phase 3 study tests whether starting a high dose of buprenorphine in the emergency department helps people with opioid use disorder come through withdrawal more safely and effectively. It focuses on people whose urine test shows fentanyl and who are already in withdrawal when they arrive.
This trial tests whether starting buprenorphine using a low-dose plan is a safe and workable way to treat opioid use disorder. You may be able to join if you are 18+, have opioid use disorder, and can follow the study medication and visits.
This trial tests whether two cannabis-like medicines, dronabinol and Epidiolex, can help reduce withdrawal symptoms and other discomforts people may feel when they first start taking buprenorphine for opioid use disorder. If you've recently started buprenorphine and still have symptoms, this study might offer extra relief.
This study tests a new way to receive buprenorphine—a once-a-month injection—from a mobile clinic that comes to you. It aims to make treatment more convenient and acceptable for people with opioid use disorder.
This study compares two methods of starting buprenorphine (a medication that helps reduce opioid cravings and withdrawal) for people who use fentanyl daily. The goal is to see which method helps people stay in treatment longer.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.